about
Human retroviral host restriction factors APOBEC3G and APOBEC3F localize to mRNA processing bodiesDeaminase-independent inhibition of parvoviruses by the APOBEC3A cytidine deaminaseEvidence for restriction of ancient primate gammaretroviruses by APOBEC3 but not TRIM5alpha proteinsRestriction of foamy viruses by APOBEC cytidine deaminasesAntiretroelement activity of APOBEC3H was lost twice in recent human evolutionAdaptive evolution and antiviral activity of the conserved mammalian cytidine deaminase APOBEC3H.Sole copy of Z2-type human cytidine deaminase APOBEC3H has inhibitory activity against retrotransposons and HIV-1TRIM family proteins: retroviral restriction and antiviral defenceMouse mammary tumor virus encodes a self-regulatory RNA export protein and is a complex retrovirus.Differential requirement for conserved tryptophans in human immunodeficiency virus type 1 Vif for the selective suppression of APOBEC3G and APOBEC3F.Hepatitis B virus replicationThe localization of APOBEC3H variants in HIV-1 virions determines their antiviral activityRegulation of aicda expression and AID activity: relevance to somatic hypermutation and class switch DNA recombinationAn extended structure of the APOBEC3G catalytic domain suggests a unique holoenzyme modelStructure, interaction and real-time monitoring of the enzymatic reaction of wild-type APOBEC3GPolymorphisms and splice variants influence the antiretroviral activity of human APOBEC3HA single amino acid difference in human APOBEC3H variants determines HIV-1 Vif sensitivityArginine methylation of the human immunodeficiency virus type 1 Tat protein by PRMT6 negatively affects Tat Interactions with both cyclin T1 and the Tat transactivation regionIdentification of amino acid residues in APOBEC3G required for regulation by human immunodeficiency virus type 1 Vif and Virion encapsidationIdentification of an infectious progenitor for the multiple-copy HERV-K human endogenous retroelements7SL RNA mediates virion packaging of the antiviral cytidine deaminase APOBEC3GNatural variation in Vif: differential impact on APOBEC3G/3F and a potential role in HIV-1 diversificationDual inhibitory effects of APOBEC family proteins on retrotransposition of mammalian endogenous retrovirusesRestricting retrotransposons: a reviewLinks between Human LINE-1 Retrotransposons and Hepatitis Virus-Related Hepatocellular CarcinomaThe role of cullin 5-containing ubiquitin ligasesCGGBP1--an indispensable protein with ubiquitous cytoprotective functionsCurrent perspectives on HIV-1 antiretroviral drug resistanceThe APOBEC3 family of retroelement restriction factorsThe role of innate APOBEC3G and adaptive AID immune responses in HLA-HIV/SIV immunized SHIV infected macaquesHepatitis C virus RNA: Dinucleotide frequencies and cleavage by RNase LCompensatory Evolution in RNA Secondary Structures Increases Substitution Rate Variation among SitesAID/APOBEC deaminases and cancerAPOBEC3A is implicated in a novel class of G-to-A mRNA editing in WT1 transcriptsLikely role of APOBEC3G-mediated G-to-A mutations in HIV-1 evolution and drug resistanceStochastic simulations suggest that HIV-1 survives close to its error thresholdMouse apolipoprotein B editing complex 3 (APOBEC3) is expressed in germ cells and interacts with dead-end (DND1)Can oncology recapitulate paleontology? Lessons from species extinctionsIntrinsic cellular defenses against human immunodeficiency virusesFootprint of APOBEC3 on the genome of human retroelements
P2860
Q21090536-B5405C8D-7173-4BD9-BBB5-29652A332238Q21131577-DB9426F6-3F53-4E25-8060-E2E266BC5FD5Q21131588-670770DB-5854-4016-A814-F483FDA7D3E7Q24299944-BF4059EE-8147-445C-870E-B894CFCDA16EQ24311460-988BA16B-1CD2-4D9A-8FFC-95EF7FFDE673Q24311896-36FEE3C9-A83F-4E71-9D8C-D0EE63F1B60AQ24317568-EFAF3E0E-F679-4D0C-97DF-4633E74B344DQ24329175-FF2EFEB8-BDCB-4D74-AB2A-67901D1454FCQ24538823-79C0A049-42AD-4884-B13D-3C32698608D5Q24544264-3C056C8A-8D1A-4F0D-A58E-31F9002BB3C9Q24563894-75F9A0BF-9B78-49A9-8B71-0ABD6EB41E24Q24596322-F40A469B-B765-4E2C-81E6-8C33ADCFC6C7Q24633098-ADD8F66C-405C-4B65-89C0-5B9635AFC12DQ24642268-EA5096CE-408C-465A-ADEF-9CEECF378137Q24649945-247F310B-92F5-40A4-8947-A3DA0F8D124AQ24655418-F058E279-95AE-4F36-8B8E-A82AD298154CQ24656551-84E480E5-0505-47B5-BD7C-407759E315FBQ24672150-F5B088FB-F0FF-4F82-AF5D-7A856365EB47Q24672209-F726CA71-492E-4491-BE3E-FA5CF3FEB2D9Q24676640-9E760B5A-C1A1-4378-864C-B5E164E71269Q24681427-931771A9-142C-4586-8F6F-7FCCB8DBEE43Q24817186-39F1E221-1E32-4570-86FE-80D105372DCEQ25257798-5191467B-9C02-44D8-ACF1-37F8D8359D29Q26741496-1693F645-9C60-4116-89B0-1E104D3D2E0DQ26744497-F12E9970-7941-4459-9217-5DAF427AEC69Q26749274-FEBA1864-11DC-43A2-9396-81EAC2898AD6Q26781725-52F779A0-8D13-459A-842B-36FC3185B523Q26852626-8145D6D6-56B4-429B-8A07-F7713F5181B0Q26862780-C5505A1D-F324-40C2-82DF-F26598BE3665Q27305204-55216CC7-BEA6-44A2-9A59-DB22105380D4Q27485064-33F9EDF0-16C0-461B-96A3-3B9A416A5BAEQ27489419-607AB700-AA23-4104-B482-D8F7BE00C766Q28085553-23AB6D97-CFAF-4706-A8B8-F6104871805EQ28259425-51D1A013-427C-4155-A56F-FC1DBA6ED55EQ28475150-4F9857C6-E42C-49E1-AFD5-83384CD13346Q28483749-B1E0FE2E-BA5E-4F8D-A441-FFF9216C9009Q28510924-ECF646A4-E080-431A-92D4-1E6D4593A0E2Q28607703-53D3BB78-B27D-4203-9B0D-E90A4778C666Q28659575-4A0DAEB5-E071-4FD2-8F03-A919D7AD403BQ28680708-472D974C-20EB-4940-B8DC-A7E0289A4418
P2860
description
2004 nî lūn-bûn
@nan
2004 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
Retroviral restriction by APOBEC proteins
@ast
Retroviral restriction by APOBEC proteins
@en
Retroviral restriction by APOBEC proteins
@nl
type
label
Retroviral restriction by APOBEC proteins
@ast
Retroviral restriction by APOBEC proteins
@en
Retroviral restriction by APOBEC proteins
@nl
prefLabel
Retroviral restriction by APOBEC proteins
@ast
Retroviral restriction by APOBEC proteins
@en
Retroviral restriction by APOBEC proteins
@nl
P2860
P3181
P356
P1476
Retroviral restriction by APOBEC proteins
@en
P2093
Mark T Liddament
P2860
P304
P3181
P356
10.1038/NRI1489
P407
P577
2004-11-01T00:00:00Z